A few words about BRAZILIAN SOCIETY OF PHARMACEUTICAL MEDICINE
The Brazilian Society of Pharmaceutical Medicine - (in Portuguese, SOCIEDADE BRASILEIRA DE MEDICINA FARMACÊUTICA - SBMF) is a non-profit organization, active throughout Brazil, with headquarters in São Paulo City. It is a study and debating center regarding the technical aspects of the work related to pharmaceutical medicine, offering guidance, support and leadership for the continual development of health professionals devoted to pharmaceutical medicine.
SBMF has been granted with stimulus and support of pharmaceutical industry associations, academic area and Brazilian health authorities. Traditionally, the President of National Health Surveillance Agency (ANVISA) is present in our annual congresses, as well as members of academy, National Ethics Committee (CONEP) and Health Ministry (DECIT/MS). Directors of SBMF has been invited to participate in commissions in the Health Ministry.
Struggling for the recognition of the specialty, SBMF has an space in the Brazilian Medical Association Journal. Recently, a pharmaceutical medicine editorial board was created and acceptation of articles on this medical area is smoothed now.
Website has been a useful tool for pharmaceutical physicians and other professionals.
History: 36 years old society
Mission: enhance the knowledge, expertise and skills of all professionals that work with Pharmaceutical Medicine promoting scientific information and appropriate use of medicines, for the benefit of patients and the society.
Membership: physicians, nurses, pharmacists, biologists, lawyers and any professionals that is involved with the delivery, regulation, surveillance or marketing of pharmaceutical or related products.
SHORT HISTORY OF SBMF
By 1969, American regulatory agencies stated that controlled clinical trials were mandatory to drug registration. A group of Brazilian physicians that was working for pharmaceutical industries realized that they needed to learn the best way to run these trials. By 1971 they joined together and founded the Brazilian Society of Pharmaceutical Medicine - SBMF (Formerly called Associação Brasileira de Médicos Assessores da Industria Farmacêutica - ABMAIF, that means Brazilian Association of Advisory Physicians to Pharmaceutical Industry).
The main purpose of this group of physicians was to be a learning nucleus for pharmaceutical physicians and a special setting where they could exchange their knowledge and skills. The association has never had a vindication interest that was left to the medical trade-union.
Since its beginning, SBMF direction has been devoted to professional progress of its associates. It has made a national congress annually. In July, 1983, ABMAIF acquired his own office, located at the commercial and hotel centre of the city of São Paulo, where most of the associates work and live.
By 1985, taking in account the high number of knowledge and skills needed to work at pharmaceutical industry, SBMF started to set the certificate of Pharmaceutical Physician. A selected group of directors of SBMF and associates wrote an ambitious design that fit with the standards settled down by Brazilian Medical Association. On strict rules, the certificate was granted to a few physicians, but there was no continuous work to achieve the needed approval of both the Federal Council of Medicine and the Brazilian Medical Association.
By the beginning of 1988, federal laws dictated rules for registration and marketing and promotion of pharmaceutical products. Physicians devoted to pharmaceutical medicine became more skilled and highly regarded.
By 1988, in the USA, health agencies dictated the first guidelines for planning, carrying out and relating of clinical trials.
By 1993, World Health Organization determined the Good Clinical Practices for clinical trials and this obligation was accepted by Brazilian health agencies as it happened in most of western countries.
By 1996, in Brazil, new federal regulations imposed Good Clinical Practices to trials as a guide for all companies.
Owing to its constant and honest work, SBMF has been granted with the real consideration of Brazilian health authorities. As a consequence, directors of SBMF have been invited to participate in commissions in the Health Ministry. Traditionally, the President of National Health Surveillance Agency is present in our congresses. Since 1995, SBMF has worked hard for achieving more consistence to the Pharmaceutical Medicine as a specialty. The first Brazilian Course of Pharmaceutical Medicine was held in 2000. The student physicians received their certificates at the XXVI Congress of the SBMF, in São Paulo.
Key issues in PM
- Priorities in the protocol writing
- How to recognize good research centers
- Negotiating costs of clinical research (industry/center)
- Regulatory affairs: from now to the future
- Improving the time study regulatory approval
- Insurance in clinical research: client and society point of view
- How to be prepared to international and FDA audits
- How to manage e-CRF and paper CRF
- Strategies to recruitment of research subjects
- Challenges in the professionalization of research centers
- Study center doesn´t go well. How to manage?
- Logistic obstacles: courier and laboratory point of view
- Are there limits do CRA professional future?
The key SBMF´s objectives are:
- Obtain recognition of Pharmaceutical Medicine as a specialty in Brazil.
- Closer relationship with International Federation of Associations of Pharmaceutical Physicians - IFAPP.
- Introduce Pharmaceutical Medicine in the Medical School curriculum and also in post graduation as extension course.
- Include Pharmaceutical Medicine representative in the editorial board of the Brazilian Medical Association Journal (Revista da Associação Médica Brasileira) - already accomplished.
- Planning and running scientific activities calendar.
Highlights on 4th Latin American Congress of Clinical Research SBMF/DIA held in São Paulo, from September 27 to 29, 2007
An exceptional congress - this is the opinion of participants from universities and industry, about 4th Latin American Congress of Clinical Research SBMF/DIA held in São Paulo, from September 27 to 29, 2007. A record number of lecturers - many of whom members of the board of directors of IFAPP - International Federation of Associations of Pharmaceutical.
Physicians, DIA - Drug Information Association, FDA - Food and Drug Administration, and EMEA - European Medicines Agency spoke at the Congress.
More than thirty national and international exhibitors participated. Due to the importance of the congress, in addition to national professionals many exhibitors were also represented by professionals from the head office or other affiliates. Variety of exhibitors also increased, and included independent research centers or research centers that cooperate with teaching institutions.
A total of nine posters were presented, and Biologist Helena Paschoale received the congress award for the study PROFILE OF CLINICAL TRIALS IN BRAZIL - PRELIMINARY RESULTS. As first author of the study, Mrs. Paschoale won a free registration and air ticket to attend the 5th Latin American Congress of Clinical Research - Regional Perspectives and Future Trends, to be held at the Sheraton Hotel, in Buenos Aires, Argentina, from November 19 to 21, 2008. This Congress is being organized by DIA and SAMEFA. - Argentinean Society of Pharmaceutical Medicine.
According to Dr. Gustavo Kesselring, president of SBMF, of 33rd Congress of SBMF and Chairperson of the 4th Latin American Congress of Clinical Research SBMF/DIA, "the main result of the congress was the discussion and the greater understanding of clinical research by professionals working in universities, industry and government".
Program Chairperson : Gustavo Luiz F. Kesselring
Program Co-Chairperson: Daniel Ciriano
Program Committee: Luis Collia, Sonia M. Dainesi, Fernanda Duran, Jorge Fiuza, Granville Garcia de Oliveira, Diego Glancszpiegel, Sergio Guerrero, Marcello Lima, Laura Luchini, Elaine Rahal, Charles Schmidt, Sergio Slawka, José Luis Viramontes
35th Brazilian Congress of Pharmaceutical Medicine
The program of the 35º Brazilian Congress of Pharmaceutical Medicine to be held on 12th to 14th November, 2009 at Maksoud Plaza Hotel, São Paulo BRAZIL, will be available soon.
SOCIEDADE BRASILEIRA DE MEDICINA FARMACÊUTICA - SBMF
Rua Pamplona 788 - 3º. Andar- Sala 32 - CEP 01405-001
Phone: 55-11-3253-2848
e-mail: sbmf@sbmf.org.br
Website: www.sbmf.org.br
